Phase 2 Breast Cancer Trial, Not Yet Recruiting NCT07103447 Sponsor: Shuangyue Liu Condition: Breast Cancer
Back to Breast Cancer

Phase 2 Breast Cancer Trial, Not Yet Recruiting

NCT07103447
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are willing to take part voluntarily, are able to sign a written consent form, and are prepared to follow all trial procedures.
  • Female participants who are aged 18 to 75 years old on the day they sign the consent form.
  • People who have been confirmed by laboratory tissue testing to have a specific type of breast cancer (triple-negative invasive breast cancer, staged T1-4N0-3M0, but not T1N0M0), meaning the cancer does not respond to estrogen, progesterone, or HER2-targeted treatments, as confirmed by specific laboratory tests.
  • People who have at least one tumour that can be measured using standard imaging criteria, and who are able to provide tumour tissue samples (either stored or freshly collected) for review.
  • People who are planned to have surgery to remove the breast cancer (either breast-conserving surgery or full breast removal), along with lymph node assessment, and who are also planned to receive chemotherapy before surgery.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have received systemic anti-cancer treatments — such as chemotherapy, radiotherapy, immunotherapy, targeted therapy, or biological agents — within 4 weeks before joining the trial (or within 2 weeks for certain targeted therapies taken as tablets or capsules).
  • People who have received local treatments aimed at relieving symptoms (palliative local treatments) within 2 weeks before joining the trial.
  • People who have received certain immune-boosting treatments (such as interleukins, interferons, or thymopeptides) within 2 weeks before joining the trial.
  • People who have used traditional Chinese medicine or Chinese patent medicines that are indicated for treating cancer within 2 weeks before joining the trial.
  • People who have previously received treatment with a type of immunotherapy called PD-1 or PD-L1 inhibitors.
  • People who are currently taking part in another clinical trial that involves an active treatment or intervention (observational studies or follow-up phases of a completed trial may be acceptable — confirm with trial site).
  • People who have been diagnosed with another cancer in the past 5 years, or who currently have another cancer, except for certain cured cancers such as basal cell skin cancer, cervical carcinoma in situ, or thyroid cancer.
  • People who have an active autoimmune disease that required systemic treatment (such as steroids) within the past 2 years, or who have an autoimmune condition that the trial doctor considers likely to return or need treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026

If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: 86 +18980606230

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Shuangyue Liu
Registry
ClinicalTrials.gov
Start date
10 September 2025
Est. completion
31 December 2027

Primary endpoints

pCR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov